comparative 1
analysis 2
prognostic 1
factor 1
models 1
follicular 1
lymphoma 2
based 1
phase 1
iii 1
trial 1
choprituximab 1
versus 1
chop 1
iodinetositumomab 1
transformed 1
nonhodgkin 1
rituximab 1
era 1
nccn 1
outcomes 1
database 1
